Cargando…
Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
SIMPLE SUMMARY: Statins have been shown to reduce the risk of gastric cancer (GC). Little is known about their effects on metachronous GC in H. pylori negative patients after endoscopic resection for early gastric cancer (EGC). In this cohort study among patients with EGC without H. pylori infection...
Autores principales: | Kwon, Tae Jin, Kim, Tae Jun, Lee, Hyuk, Min, Yang Won, Min, Byung-Hoon, Lee, Jun Haeng, Kim, Jae J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957799/ https://www.ncbi.nlm.nih.gov/pubmed/33804425 http://dx.doi.org/10.3390/cancers13051020 |
Ejemplares similares
-
Aspirin Use Is Not Associated with the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
por: Kim, Ji Eun, et al.
Publicado: (2021) -
Association between Helicobacter pylori status and metachronous gastric cancer after endoscopic resection
por: Kim, Sung Bum, et al.
Publicado: (2016) -
Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015) -
Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
por: Han, Seung Jun, et al.
Publicado: (2018) -
Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer
por: Bang, Chang Seok, et al.
Publicado: (2015)